OB-GYN Dr. Thaïs Aliabadi said she's seen an uptick in younger cancer patients. She shared her best cancer prevention tips.

In an interview with Targeted Oncology, Erin Crane, MD, MPH, discusses PARP inhibitor restrictions in gynecologic oncology. Watch part 1 of the interview here.

Immunotherapy given before or after surgery is increasingly used across several cancer areas. In an article published in the Journal of Internal Medicine, researchers at Karolinska Institutet present ...

Molecular profiling guides ovarian cancer maintenance: HRD and BRCA results steer PARP inhibitors, bevacizumab choices, and patient counseling.

Hormonal and Pathophysiological Drivers: The increased cancer risk is largely driven by hyperinsulinemia suppressing sex hormone-binding globulin (SHBG), which raises circulating estrogen and ...

Researchers analyzed data from 1,903 patients with stage 3 or stage 4 epithelial ovarian cancer who were enrolled in four ...

Ovarian cancer is still one of the deadliest gynecological cancers affecting women around the world, especially in East Asian countries, where the numbers keep rising year after year. A new nationwide ...

Women should begin annual mammograms at age 40, according to updated medical guidance that follows years of debate over when ...

Study to be presented at this year's ESGO 2026 , demonstrates significant overall survival benefit with Elenagen plus ...

Feb 13 () - Patients with one of the deadliest gynecological cancers had dramatically improved survival when an experimental ...

Amy Comander, MD, discusses how breast cancer survivors can improve their health and quality of life in “PAVING Your Path ...

Peer-reviewed journals, major news outlets, government agencies, universities, and nonprofit organizations are generally considered evidence-based, reliable sources. Many of these sources offer ...